SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001650664-23-000014
Filing Date
2023-11-03
Accepted
2023-11-03 07:06:23
Documents
14
Period of Report
2023-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20231103.htm   iXBRL 8-K 27936
2 EX-99.1 a2023_q3earningsrelease.htm EX-99.1 65268
6 edit-20230802xex99d1001.jpg GRAPHIC 6224
  Complete submission text file 0001650664-23-000014.txt   237458

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20231103.xsd EX-101.SCH 1994
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20231103_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20231103_pre.xml EX-101.PRE 12591
8 EXTRACTED XBRL INSTANCE DOCUMENT edit-20231103_htm.xml XML 2714
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 231374471
SIC: 2836 Biological Products, (No Diagnostic Substances)